HSU ERIC C — SEC Form 4 filings

SEC reporting owner CIK 1817867. 5 Form 4 filings on record with FilingPulse; latest filed 2025-12-19.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-05 to 2025-12-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
InMed Pharmaceuticals Inc. (INM)Sr. VP, Pre-Clinical Res/Dev55

Form 4 filings — HSU ERIC C

FiledFormIssuerReported transactionsSource
2025-12-194InMed Pharmaceuticals Inc. (INM)Grant/award (A): 13,000 (derivative) @ $0EDGAR
2025-12-174InMed Pharmaceuticals Inc. (INM)Code (H): 70 (derivative) @ $0EDGAR
2024-12-234InMed Pharmaceuticals Inc. (INM)Grant/award (A): 2,750 (derivative) @ $0EDGAR
2024-05-284InMed Pharmaceuticals Inc. (INM)Code (H): 545 (derivative) @ $0EDGAR
2024-03-054InMed Pharmaceuticals Inc. (INM)Code (H): 309 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817867 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →